Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review

Cannabidiol and related cannabinoids are under exploration for the treatment of a number of disease states. The cannabinoid-quinone HU-331 has been studied as a potential anticancer therapeutic. Previous studies provide evidence that HU-331 displays anticancer activity without some of the known adve...

Descripción completa

Detalles Bibliográficos
Autores principales: Trac, Judy, Keck, J. Myles, Deweese, Joseph E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067350/
https://www.ncbi.nlm.nih.gov/pubmed/33892826
http://dx.doi.org/10.1186/s42238-021-00067-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067350/
https://www.ncbi.nlm.nih.gov/pubmed/33892826
http://dx.doi.org/10.1186/s42238-021-00067-z

Ejemplares similares